Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00417456 · ClinicalTrials.gov registry record · NA
The Development and Evaluation of an "E-Visit" Program for the Management of Acne
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 151
- Enrollment target
NCT00417456: Completed NA study, sponsored by Massachusetts General Hospital.
NCT00417456 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 151 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00417456, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 151 participants
- Enrollment target
Study Summary
The purpose of this study is to test the efficacy, timeliness, and user satisfaction of an online "E-Visit" application that uses store-and-forward technology for acne patients requiring dermatologic care for their condition. Hypotheses: 1. That an "E-Visit" is an effective alternative to in-person clinic care for patients with mild to severe facial acne. 2. That providers and patients will be satisfied with this model. 3. That mean wait times for new and return visits will be reduced through the "E-Visit" model. 4. That this prototype for care will improve clinic workflow, offer additional patient access, and allow urgent cases to be seen earlier.
Interventions
- OTHER Evisit
- OTHER Office visit
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 151 participants |
| Start Date | 2005-10 |
| Est. Completion | 2007-12 |
| Phase | NA |
What the finished NCT00417456 record still lists
NCT00417456 is an interventional study that assigns participants to a tested intervention. The registered 151 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower).
The record links to 0 conditions, and to 2 interventions - of which Evisit is the first listed.
NCT00417456 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00417456 about?
NCT00417456 is a clinical study titled "The Development and Evaluation of an "E-Visit" Program for the Management of Acne". The purpose of this study is to test the efficacy, timeliness, and user satisfaction of an online "E-Visit" application that uses store-and-forward technology for acne patients requiring dermatologic care for their condition. Hypotheses: 1. That an "E-Visit" is an effective alternative to in-person...
What is the current status of trial NCT00417456?
This trial is currently completed. It is a NA study. The enrollment target is 151 participants. The study started on 2005-10. Estimated completion is 2007-12.
What interventions are being tested in trial NCT00417456?
The interventions under investigation include: Evisit (OTHER), Office visit (OTHER).
Who is sponsoring clinical trial NCT00417456?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00417456's enrollment target sits among peer trials
151 661st of 2000 higher than 1,340 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01409161 · 151 participants · Phase 2
Tretinoin and Arsenic Trioxide With or Without Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia
- NCT04245397 · 151 participants · Phase 1
Study of SX-682 Alone and in Combination With Oral or Intravenous Decitabine in Subjects With Myelodysplastic Syndrome
- NCT05761223 · 151 participants · Phase 1
A Phase I/II, Open-label Study to Investigate the Safety, Tolerability, PK, and Preliminary Efficacy of FB849
- NCT07195656 · 151 participants · NA
Evaluation of a Non-Implanted Electrical Stimulation Device for Overactive Bladder (OAB)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia